Skip to main content

Amedisys Value Stock - Dividend - Research Selection

Amedisys

ISIN: US0234361089 , WKN: 915582

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield%
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



DescriptionData
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and Personal Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses, physical and speech therapists, occupational therapists, and aides for its patients to complete their important personal tasks. The Hospice segment offers care that is designed to provide comfort and support for those who are dealing with a terminal illness, including heart disease, pulmonary disease, Alzheimer\'s, HIV/AIDS, and cancer. The Personal Care segment provides assistance for patients with the activities of daily living. As of February 27, 2018, the company owned and operated 421 care centers in 34 states. Amedisys, Inc. was founded in 1982 and is headquartered in Baton Rouge, Louisiana.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


Merger Arbitrage: Energized By All-Stock Transactions In Oil & Gas

2024-10-03
From a valuation perspective, all-stock transactions can mitigate the complexities of determining fair value in a sector prone to cyclical swings. Click to read.

Amedisys (AMED) Moves to Buy: Rationale Behind the Upgrade

2024-09-30
Amedisys (AMED) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

AMED or CHE: Which Is the Better Value Stock Right Now?

2024-09-30
AMED vs. CHE: Which Stock Is the Better Value Option?

Amedisys has earned the 2023 SHPBest™ Patient Satisfaction Awards

2024-09-25
BATON ROUGE, La., Sept. 25, 2024 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice and high-acuity care in the home, has 92 home health and hospice care centers recognized by Strategic Healthcare Programs (SHP) for achieving the highest overall HHCAHPS patient satisfaction or CAHPS Hospice caregiver satisfaction scores of all eligible SHP clients in 2023. This includes 14 care centers awarded Premier Performer, ranking in the top 5%, and 78 care center

Amedisys has earned the 2023 SHPBest? Patient Satisfaction Awards

2024-09-25
Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

Amedisys sale to UnitedHealth unlikely to be done until at least end of November

2024-09-18
Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

BrightSpring Health Services: Evaluating The Investment Case Seven Months Post-IPO

2024-08-29
BrightSpring Health Services stock has underperformed since its IPO. Check out why BTSG stock presents a mixed investment case.

Contessa Selected by Centers for Medicare & Medicaid Services to Test Medicare Dementia Care Model

2024-08-21
Guiding an Improved Dementia Experience (GUIDE) Model Aims to Increase Care Coordination, Support for CaregiversNASHVILLE, Tenn., Aug. 21, 2024 (GLOBE NEWSWIRE) -- Today, Contessa Health, a subsidiary of Amedisys Inc. (Nasdaq: AMED), announced they have been selected by the Centers for Medicare & Medicaid Services (CMS) to participate in a new Medicare alternative payment model designed to support people living with dementia and their caregivers. Under CMS’ Guiding an Improved Dementia Experienc

Top Merger Stocks Held By Fund Managers, Mid-Q3 2024

2024-08-17
Merger arbitrage investors face challenges with deals in limbo, but retain confidence in top holdings Hess Corp and HashiCorp amid pending acquisitions.

Amedisys just downgraded at Deutsche Bank, here's why

2024-07-29
Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.